These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 30711986)

  • 1. Significance of Lateral Pelvic Lymph Node Size in Predicting Metastasis and Prognosis in Rectal Cancer.
    Lee D; Matsuda T; Yamashita K; Hasegawa H; Yamamoto M; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Fukumoto T; Kakeji Y
    Anticancer Res; 2019 Feb; 39(2):993-998. PubMed ID: 30711986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between the sizes of lateral pelvic lymph nodes and metastases in rectal cancer patients treated with preoperative chemoradiotherapy.
    Ishihara S; Kawai K; Tanaka T; Hata K; Nozawa H
    ANZ J Surg; 2018 Dec; 88(12):1306-1310. PubMed ID: 29974631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
    Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
    BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
    Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
    World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
    Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
    Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
    Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is laparoscopic selective lateral lymph node dissection for locally advanced rectal cancer after neoadjuvant chemoradiotherapy safe?
    Yang X; Gu C; Hu T; Bi L; Wei M; Deng X; Wang Z; Zhou Z
    ANZ J Surg; 2019 Nov; 89(11):E492-E497. PubMed ID: 31566296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial.
    Wei M; Wu Q; Fan C; Li Y; Chen X; Zhou Z; Han J; Wang Z
    Trials; 2016 Nov; 17(1):561. PubMed ID: 27884204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative lateral lymph node features and impact on local recurrence after neoadjuvant chemoradiotherapy and total mesorectal excision for locally advanced rectal cancer: results from a multicentre international cohort study.
    Achilli P; Ferrari D; Calini G; Bertoglio CL; Magistro C; Origi M; Carnevali P; Alampi BD; Giusti I; Ferrari G; Calafiore E; Spinelli A; Grass F; Deslarzes P; Hahnloser D; Abdalla S; Larson DW
    Colorectal Dis; 2024 Mar; 26(3):466-475. PubMed ID: 38243617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chemoradiotherapy changes the size criterion for predicting lateral lymph node metastasis in lower rectal cancer.
    Yamaoka Y; Kinugasa Y; Shiomi A; Yamaguchi T; Kagawa H; Yamakawa Y; Numata M; Furutani A
    Int J Colorectal Dis; 2017 Nov; 32(11):1631-1637. PubMed ID: 28762190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the viability assessment of lateral lymph node metastasis in rectal cancer after neoadjuvant chemoradiotherapy.
    Ozaki K; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Abe H; Ushiku T; Ishihara S
    Int J Colorectal Dis; 2022 Feb; 37(2):467-473. PubMed ID: 35064299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Significance of Isolated Tumor Cells Detected Within Lateral Lymph Nodes in Rectal Cancer Patients After Laparoscopic Lateral Lymph Node Dissection.
    Yang X; Hu T; Gu C; Yang S; Jiang D; Deng X; Wang Z; Zhou Z
    J Laparoendosc Adv Surg Tech A; 2019 Nov; 29(11):1462-1468. PubMed ID: 31539301
    [No Abstract]   [Full Text] [Related]  

  • 14. Preoperative Chemoradiotherapy Might Improve the Prognosis of Patients with Locally Advanced Low Rectal Cancer and Lateral Pelvic Lymph Node Metastases.
    Nagasaki T; Akiyoshi T; Fujimoto Y; Konishi T; Nagayama S; Fukunaga Y; Ueno M
    World J Surg; 2017 Mar; 41(3):876-883. PubMed ID: 27730348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
    Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
    Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lateral lymph nodes without malignant characteristics on the prognosis of patients with rectal cancer.
    Zhang C; Cui M; Xing J; Yang H; Yao Z; Zhang N; Tan F; Liu M; Xu K; Su X
    Future Oncol; 2022 Oct; 18(31):3509-3518. PubMed ID: 36317561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between the Recurrence Patterns and Sizes of Lateral Pelvic Lymph Nodes before and after Chemoradiotherapy in Patients with Lower Rectal Cancer.
    Shiratori H; Kawai K; Hata K; Tanaka T; Nishikawa T; Sasaki K; Kaneko M; Murono K; Emoto S; Morikawa T; Fukayama M; Nozawa H
    Oncology; 2019; 96(1):33-43. PubMed ID: 30212816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between preoperative chemoradiotherapy and lateral pelvic lymph node dissection in clinical T3 low rectal cancer without enlarged lateral lymph nodes.
    Tsukada Y; Rullier E; Shiraishi T; Capdepont M; Sasaki T; Celerier B; Denost Q; Ito M
    Colorectal Dis; 2023 Jun; 25(6):1153-1162. PubMed ID: 36932710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
    Li C; Luan J; Ji X; Wang X; Li J; Li X; Zhou Y
    J Surg Oncol; 2024 Feb; 129(2):273-283. PubMed ID: 37811551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications and oncological outcomes of selective dissection for clinically suspected lateral lymph node metastasis in patients with rectal cancer based on pretreatment imaging.
    Yang X; Gu C; Hu T; Wei M; Meng W; Wang Z; Deng X; Zhou Z
    Tech Coloproctol; 2021 Apr; 25(4):425-437. PubMed ID: 33585985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.